EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF
US Application 62/782,809
Filed on 2018-12-20
Filed on 2018-12-20
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
US Application 62/735,188
Filed on 2018-09-23
Filed on 2018-09-23
USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION
US Application 62/737,899
Filed on 2018-09-27
Filed on 2018-09-27
Improved Methods Of Manufacturing Peptide-Based Vaccines
US Application 62/674,752
Filed on 2018-05-22
Filed on 2018-05-22
A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS
US Application 62/751,204
Filed on 2018-10-26
Filed on 2018-10-26
NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION
US Application 62/682,678
Filed on 2018-06-08
Filed on 2018-06-08
Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response
US Application 62/481,432
Filed on 2017-04-04
Filed on 2017-04-04
Zika Viral Antigen Constructs
US Application 62/568,559
Filed on 2017-10-05
Filed on 2017-10-05
Zika Viral Antigen Constructs
US Application 62/485,090
Filed on 2017-04-13
Filed on 2017-04-13
Zika Viral Antigen Constructs
US Application 62/423,398
Filed on 2016-11-17
Filed on 2016-11-17